Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL et al (2011) High density DNA methylation array with single CpG site resolution. Genomics 98:288–295. https://doi.org/10.1016/j.ygeno.2011.07.007
Article
CAS
PubMed
Google Scholar
Brat DJ (2012) Glioblastoma: biology, genetics, and behavior. Am Soc Clin Oncol Educ Book. https://doi.org/10.14694/EdBook_AM.2012.32.48
Article
PubMed
Google Scholar
Brat DJ, Castellano-Sanchez AA, Hunter SB, Pecot M, Cohen C, Hammond EH, Devi SN, Kaur B, Van Meir EG (2004) Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res 64:920–927. https://doi.org/10.1158/0008-5472.can-03-2073
Article
CAS
PubMed
Google Scholar
Brat DJ, Van Meir EG (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84:397–405. https://doi.org/10.1038/labinvest.3700070
Article
CAS
PubMed
Google Scholar
Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474. https://doi.org/10.1038/nature26000
Article
CAS
PubMed
PubMed Central
Google Scholar
Chakravarthy A, Furness A, Joshi K, Ghorani E, Ford K, Ward MJ, King EV, Lechner M, Marafiorti T, Quezada SA et al (2018) Pan-cancer deconvolution of tumour composition using DNA methylation. Nat Commun 9:3220. https://doi.org/10.1038/s41467-018-05570-1
Article
CAS
PubMed
PubMed Central
Google Scholar
Euskirchen P, Bielle F, Labreche K, Kloosterman WP, Rosenberg S, Daniau M, Schmitt C, Masliah-Planchon J, Bourdeaut F, Dehais C et al (2017) Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing. Acta Neuropathol 134:691–703. https://doi.org/10.1007/s00401-017-1743-5
Article
CAS
PubMed
PubMed Central
Google Scholar
Fan C-H, Liu W-L, Cao H, Wen C, Chen L, Jiang G (2013) O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death Dis 4:e876. https://doi.org/10.1038/cddis.2013.388
Article
CAS
PubMed
PubMed Central
Google Scholar
Fine HA (2015) New strategies in glioblastoma: exploiting the new biology. Clin Cancer Res 21:1984–1988. https://doi.org/10.1158/1078-0432.CCR-14-1328
Article
CAS
PubMed
Google Scholar
Georgescu M-M, Olar A (2020) Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma. Acta Neuropathol Commun 8:10. https://doi.org/10.1186/s40478-020-0889-x
Article
CAS
PubMed
PubMed Central
Google Scholar
Gittleman H, Boscia A, Ostrom QT, Truitt G, Fritz Y, Kruchko C, Barnholtz-Sloan JS (2018) Survivorship in adults with malignant brain and other central nervous system tumor from 2000–2014. Neuro Oncol 20:vii6–vii16. https://doi.org/10.1093/neuonc/noy090
Article
PubMed
PubMed Central
Google Scholar
Gitto L, Serinelli S, Galbraith K, Williams M, Mirchia K, Galgano MA, Krishnamurthy S, de la Roza G, Viapiano MS, Walker JM et al (2020) Anaplastic transformation in myxopapillary ependymoma: a report of 2 cases and review of the literature. J Neuropathol Exp Neurol 79:1044–1053. https://doi.org/10.1093/jnen/nlaa077
Article
PubMed
Google Scholar
Gonzalez Castro LN, Wesseling P (2020) The cIMPAC-NOW updates and their significance to current neuro-oncology practice. Neurooncol Pract 8:4–10. https://doi.org/10.1093/nop/npaa055
Article
PubMed
PubMed Central
Google Scholar
Hench J, Bihl M, Bratic Hench I, Hoffmann P, Tolnay M, Bosch Al Jadooa N, Mariani L, Capper D, Frank S (2018) Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics. Neuro Oncol 20:1682–1683. https://doi.org/10.1093/neuonc/noy128
Article
PubMed
PubMed Central
Google Scholar
Huse JT, Snuderl M, Jones DT, Brathwaite CD, Altman N, Lavi E, Saffery R, Sexton-Oates A, Blumcke I, Capper D et al (2017) Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. Acta Neuropathol 133:417–429. https://doi.org/10.1007/s00401-016-1639-9
Article
CAS
PubMed
Google Scholar
Jaunmuktane Z, Capper D, Jones DTW, Schrimpf D, Sill M, Dutt M, Suraweera N, Pfister SM, von Deimling A, Brandner S (2019) Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single center. Acta Neuropathol Commun 7:24. https://doi.org/10.1186/s40478-019-0668-8
Article
PubMed
PubMed Central
Google Scholar
Kahn S, Mittal S, McGee K, Alfaro-Munoz KD, Majd N, Balasubramaniyan V, de Groot JF (2020) Role of neutrophils and myeloid-derived suppressor cells in glioma progression and treatment resistance. Int J Mol Sci 21:1954. https://doi.org/10.3390/ijms21061954
Article
CAS
Google Scholar
Kulis M, Esteller M (2010) DNA methylation and cancer. Adv Genet 70:27–56. https://doi.org/10.1016/B978-0-12-380866-0.60002-2
Article
PubMed
Google Scholar
Louis DN (2006) Molecular pathology of malignant gliomas. Annu Rev Pathol 1:97–117. https://doi.org/10.1146/annurev.pathol.1.110304.100043
Article
CAS
PubMed
Google Scholar
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1
Article
PubMed
Google Scholar
Louis DN, Wesseling P, Aldape K, Brat DJ, Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M, Fuller GN et al (2020) cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 30:844–856. https://doi.org/10.1111/bpa.12832
Article
PubMed
PubMed Central
Google Scholar
Lu VM, O’Connor KP, Shah AH, Eichberg DG, Luther EM, Komotar RJ, Ivan ME (2020) The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature. J Neurooncol 148:221–229. https://doi.org/10.1007/s11060-020-03528-2
Article
CAS
PubMed
Google Scholar
Luczak MW, Jagodziński PP (2006) The role of DNA methylation in cancer development. Folia Histochem Cytobiol 44:143–154
CAS
PubMed
Google Scholar
Mansouri A, Hachem LD, Mansouri S, Nassiri F, Laperriere NJ, Xia D, Lindeman NI, Wen PY, Chakravarti A, Mehta MP et al (2019) MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges. Neuro Oncol 21:167–178. https://doi.org/10.1093/neuonc/noy132
Article
CAS
PubMed
Google Scholar
Meyer M, Reimand J, Lan X, Head R, Zhu X, Kushida M, Bayani J, Pressey JC, Lionel AC, Clarke ID et al (2015) Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity. Proc Natl Acad Sci U S A 112:851–856. https://doi.org/10.1073/pnas.1320611111
Article
CAS
PubMed
PubMed Central
Google Scholar
Mirchia K, Richardson TE (2020) Beyond IDH-mutation: emerging molecular diagnostic and prognostic features in adult diffuse gliomas. Cancers (Basel). https://doi.org/10.3390/cancers12071817
Article
Google Scholar
Orillac C, Thomas C, Dastagirzada Y, Hidalgo ET, Golfinos JG, Zagzag D, Wisoff JH, Karajannis MA, Snuderl M (2016) Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation. Acta Neuropathol Commun 4:84. https://doi.org/10.1186/s40478-016-0361-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro Oncol 21:v1–v100. https://doi.org/10.1093/neuonc/noz150
Article
PubMed
PubMed Central
Google Scholar
Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401. https://doi.org/10.1126/science.1254257
Article
CAS
PubMed
PubMed Central
Google Scholar
Priesterbach-Ackley LP, Boldt HB, Petersen JK, Bervoets N, Scheie D, Ulhøi BP, Gardberg M, Brännström T, Torp SH, Aronica E et al (2020) Brain tumour diagnostics using a DNA-methylation-based classifier as a diagnostic support tool. Neuropathol Appl Neurobiol 46:478–492. https://doi.org/10.1111/nan.12610
Article
CAS
PubMed
PubMed Central
Google Scholar
Richardson TE, Kumar A, Xing C, Hatanpaa KJ, Walker JM (2020) Overcoming the odds: toward a molecular profile of long-term survival in glioblastoma. J Neuropathol Exp Neurol 79:1031–1037. https://doi.org/10.1093/jnen/nlaa102
Article
PubMed
Google Scholar
Richardson TE, Patel S, Serrano J, Sathe AA, Daoud EV, Oliver D, Maher EA, Madrigales A, Mickey BE, Taxter T et al (2019) Genome-wide analysis of glioblastoma patients with unexpectedly long survival. J Neuropathol Exp Neurol 78:501–507. https://doi.org/10.1093/jnen/nlz025
Article
CAS
PubMed
Google Scholar
Richardson TE, Sathe AA, Xing C, Mirchia K, Viapiano MS, Snuderl M, Abdullah KG, Hatanpaa KJ, Walker JM (2021) Molecular signatures of chromosomal instability correlate with copy number variation patterns and patient outcome in IDH-mutant and IDH-wildtype astrocytomas. J Neuropathol Exp Neurol 80:354–365. https://doi.org/10.1093/jnen/nlab008
Article
PubMed
Google Scholar
Richardson TE, Snuderl M, Serrano J, Karajannis MA, Heguy A, Oliver D, Raisanen JM, Maher EA, Pan E, Barnett S et al (2017) Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis. J Neurooncol 133:183–192. https://doi.org/10.1007/s11060-017-2431-y
Article
CAS
PubMed
Google Scholar
Richardson TE, Tang K, Vasudevaraja V, Serrano J, William CM, Mirchia K, Pierson CR, Leonard JR, AbdelBaki MS, Schieffer KM et al (2019) GOPC-ROS1 fusion due to microdeletion at 6q22 is an oncogenic driver in a subset of pediatric gliomas and glioneuronal tumors. J Neuropathol Exp Neurol 78:1089–1099. https://doi.org/10.1093/jnen/nlz093
Article
CAS
PubMed
Google Scholar
Rong Y, Durden DL, Van Meir EG, Brat DJ (2006) ‘Pseudopalisading’ necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 65:529–539
Article
PubMed
Google Scholar
Schäfer N, Gielen GH, Rauschenbach L, Kebir S, Till A, Reinartz R, Simon M, Niehusmann P, Kleinschnitz C, Herrlinger U et al (2019) Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors. J Transl Med 17:96. https://doi.org/10.1186/s12967-019-1846-y
Article
PubMed
PubMed Central
Google Scholar
Serrano J, Snuderl M (2018) Whole genome DNA methylation analysis of human glioblastoma using Illumina BeadArrays. Methods Mol Biol 1741:31–51. https://doi.org/10.1007/978-1-4939-7659-1_2
Article
CAS
PubMed
Google Scholar
Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, Pfaff E, Tonjes M, Sill M, Bender S et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437. https://doi.org/10.1016/j.ccr.2012.08.024
Article
CAS
PubMed
Google Scholar
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550. https://doi.org/10.1073/pnas.0506580102
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang K, Kurland D, Vasudevaraja V, Serrano J, DeLorenzo M, Radmanesh A, Thomas C, Spino M, Gardner S, Allen JC et al (2020) Exploring DNA methylation for prognosis and analyzing the tumor microenvironment in pleomorphic xanthoastrocytoma. J Neuropathol Exp Neurol 79:880–890. https://doi.org/10.1093/jnen/nlaa051
Article
PubMed
PubMed Central
Google Scholar
Wiestler B, Capper D, Hovestadt V, Sill M, Jones DT, Hartmann C, Felsberg J, Platten M, Feiden W, Keyvani K et al (2014) Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial. Neuro Oncol 16:1630–1638. https://doi.org/10.1093/neuonc/nou138
Article
CAS
PubMed
PubMed Central
Google Scholar
Wiestler B, Capper D, Sill M, Jones DT, Hovestadt V, Sturm D, Koelsche C, Bertoni A, Schweizer L, Korshunov A et al (2014) Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathol 128:561–571. https://doi.org/10.1007/s00401-014-1315-x
Article
CAS
PubMed
Google Scholar
Yu Y, Villanueva-Meyer J, Grimmer MR, Hilz S, Solomon DA, Choi S, Wahl M, Mazor T, Hong C, Shai A et al (2021) Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas. Neuro Oncol. https://doi.org/10.1093/neuonc/noab081
Article
PubMed
PubMed Central
Google Scholar
Zhao Y, Carter R, Natarajan S, Varn FS, Compton DA, Gawad C, Cheng C, Godek KM (2019) Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells. BMC Med Genom 12:79. https://doi.org/10.1186/s12920-019-0532-5
Article
CAS
Google Scholar